Compare UPC & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPC | DRCT |
|---|---|---|
| Founded | 1998 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 2.3M |
| IPO Year | 2020 | 2021 |
| Metric | UPC | DRCT |
|---|---|---|
| Price | $3.24 | $3.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 12.5K | ★ 27.6K |
| Earning Date | 01-29-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,694,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | N/A | $9.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.00 | $0.04 |
| 52 Week High | $11.00 | $7.21 |
| Indicator | UPC | DRCT |
|---|---|---|
| Relative Strength Index (RSI) | 51.20 | 49.29 |
| Support Level | $2.69 | $2.73 |
| Resistance Level | $3.30 | $3.30 |
| Average True Range (ATR) | 0.36 | 0.22 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 53.78 | 35.54 |
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.